Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 RNAaemia predicts clinical deterioration and extrapulmonary complications from COVID-19

View ORCID ProfileNikhil Ram-Mohan, David Kim, Elizabeth J Zudock, Marjan M Hashemi, Kristel C Tjandra, Angela J Rogers, Catherine A Blish, Kari C. Nadeau, Jennifer A Newberry, James V Quinn, Ruth O’Hara, Euan Ashley, Hien Nguyen, Lingxia Jiang, Paul Hung, the Stanford COVID-19 Biobank Study Group, Andra L Blomkalns, Samuel Yang
doi: https://doi.org/10.1101/2020.12.19.20248561
Nikhil Ram-Mohan
1Department of Emergency Medicine, Stanford University School of Medicine, Palo Alto CA 94305
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nikhil Ram-Mohan
David Kim
1Department of Emergency Medicine, Stanford University School of Medicine, Palo Alto CA 94305
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth J Zudock
1Department of Emergency Medicine, Stanford University School of Medicine, Palo Alto CA 94305
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marjan M Hashemi
1Department of Emergency Medicine, Stanford University School of Medicine, Palo Alto CA 94305
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristel C Tjandra
1Department of Emergency Medicine, Stanford University School of Medicine, Palo Alto CA 94305
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angela J Rogers
2Department of Medicine - Pulmonary, Allergy & Critical Care Medicine, Stanford University School of Medicine, Palo Alto CA 94305
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine A Blish
3Department of Medicine/Infectious Diseases, Stanford University School of Medicine, Palo Alto CA 94305
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kari C. Nadeau
2Department of Medicine - Pulmonary, Allergy & Critical Care Medicine, Stanford University School of Medicine, Palo Alto CA 94305
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer A Newberry
1Department of Emergency Medicine, Stanford University School of Medicine, Palo Alto CA 94305
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James V Quinn
1Department of Emergency Medicine, Stanford University School of Medicine, Palo Alto CA 94305
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruth O’Hara
4Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto CA 94305
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Euan Ashley
5Department of Medicine – Cardiovascular Medicine, Stanford University School of Medicine, Palo Alto CA 94305
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hien Nguyen
6COMBiNATi Inc., 2450 Embarcadero Way, Palo Alto CA 94303
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lingxia Jiang
6COMBiNATi Inc., 2450 Embarcadero Way, Palo Alto CA 94303
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Hung
6COMBiNATi Inc., 2450 Embarcadero Way, Palo Alto CA 94303
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andra L Blomkalns
1Department of Emergency Medicine, Stanford University School of Medicine, Palo Alto CA 94305
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samuel Yang
1Department of Emergency Medicine, Stanford University School of Medicine, Palo Alto CA 94305
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: syang5@stanford.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The determinants of COVID-19 disease severity and extrapulmonary complications (EPCs) are poorly understood. We characterise the relationships between SARS-CoV-2 RNAaemia and disease severity, clinical deterioration, and specific EPCs.

Methods We used quantitative (qPCR) and digital (dPCR) PCR to quantify SARS-CoV-2 RNA from nasopharyngeal swabs and plasma in 191 patients presenting to the Emergency Department (ED) with COVID-19. We recorded patient symptoms, laboratory markers, and clinical outcomes, with a focus on oxygen requirements over time. We collected longitudinal plasma samples from a subset of patients. We characterised the role of RNAaemia in predicting clinical severity and EPCs using elastic net regression.

Findings 23·0% (44/191) of SARS-CoV-2 positive patients had viral RNA detected in plasma by dPCR, compared to 1·4% (2/147) by qPCR. Most patients with serial measurements had undetectable RNAaemia 10 days after onset of symptoms, but took 16 days to reach maximum severity, and 33 days for symptoms to resolve. Initially RNAaemic patients were more likely to manifest severe disease (OR 6·72 [95% CI, 2·45 – 19·79]), worsening of disease severity (OR 2·43 [95% CI, 1·07 - 5·38]), and EPCs (OR 2·81 [95% CI, 1·26 – 6·36]). RNA load correlated with maximum severity (r = 0·47 [95% CI, 0·20 - 0·67]).

Interpretation dPCR is more sensitive than qPCR for the detection of SARS-CoV-2 RNAaemia, which is a robust predictor of eventual COVID-19 severity and oxygen requirements, as well as EPCs. Since many COVID-19 therapies are initiated on the basis of oxygen requirements, RNAaemia on presentation might serve to direct early initiation of appropriate therapies for the patients most likely to deteriorate.

Funding NIH/NIAID (Grants R01A153133, R01AI137272, and 3U19AI057229 – 17W1 COVID SUPP #2) and a donation from Eva Grove.

Evidence before this study The varied clinical manifestations of COVID-19 have directed attention to the distribution of SARS-CoV-2 in the body. Although most concentrated and tested for in the nasopharynx, SARS-CoV-2 RNA has been found in blood, stool, and numerous tissues, raising questions about dissemination of viral RNA throughout the body, and the role of this process in disease severity and extrapulmonary complications. Recent studies have detected low levels of SARS-CoV-2 RNA in blood using either quantitative reverse transcriptase real-time PCR (qPCR) or droplet digital PCR (dPCR), and have associated RNAaemia with disease severity and biomarkers of dysregulated immune response.

Added value of this study We quantified SARS-CoV-2 RNA in the nasopharynx and plasma of patients presenting to the Emergency Department with COVID-19, and found an array-based dPCR platform to be markedly more sensitive than qPCR for detection of SARS-CoV-2 RNA, with a simplified workflow well-suited to clinical adoption. We collected serial plasma samples during patients’ course of illness, and showed that SARS-CoV-2 RNAaemia peaks early, while clinical condition often continues to worsen. Our findings confirm the association between RNAaemia and disease severity, and additionally demonstrate a role for RNAaemia in predicting future deterioration and specific extrapulmonary complications.

Implications of all the available evidence Variation in SARS-CoV-2 RNAaemia may help explain disparities in disease severity and extrapulmonary complications from COVID-19. Testing for RNAaemia with dPCR early in the course of illness may help guide patient triage and management.

Competing Interest Statement

SY is a Scientific Advisory Board member of COMBiNATi Inc.

Funding Statement

NIH/NIAID (Grants R01A153133, R01AI137272, and 3U19AI057229-17W1 COVID SUPP #2) and a donation from Eva Grove.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Stanford University ED COVID-19 Biobank IRB-approved (eP-55650)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

De-identified study data are presented as online datasets.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 22, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 RNAaemia predicts clinical deterioration and extrapulmonary complications from COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 RNAaemia predicts clinical deterioration and extrapulmonary complications from COVID-19
Nikhil Ram-Mohan, David Kim, Elizabeth J Zudock, Marjan M Hashemi, Kristel C Tjandra, Angela J Rogers, Catherine A Blish, Kari C. Nadeau, Jennifer A Newberry, James V Quinn, Ruth O’Hara, Euan Ashley, Hien Nguyen, Lingxia Jiang, Paul Hung, the Stanford COVID-19 Biobank Study Group, Andra L Blomkalns, Samuel Yang
medRxiv 2020.12.19.20248561; doi: https://doi.org/10.1101/2020.12.19.20248561
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
SARS-CoV-2 RNAaemia predicts clinical deterioration and extrapulmonary complications from COVID-19
Nikhil Ram-Mohan, David Kim, Elizabeth J Zudock, Marjan M Hashemi, Kristel C Tjandra, Angela J Rogers, Catherine A Blish, Kari C. Nadeau, Jennifer A Newberry, James V Quinn, Ruth O’Hara, Euan Ashley, Hien Nguyen, Lingxia Jiang, Paul Hung, the Stanford COVID-19 Biobank Study Group, Andra L Blomkalns, Samuel Yang
medRxiv 2020.12.19.20248561; doi: https://doi.org/10.1101/2020.12.19.20248561

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (180)
  • Allergy and Immunology (435)
  • Anesthesia (99)
  • Cardiovascular Medicine (949)
  • Dentistry and Oral Medicine (178)
  • Dermatology (111)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (423)
  • Epidemiology (9014)
  • Forensic Medicine (4)
  • Gastroenterology (422)
  • Genetic and Genomic Medicine (1963)
  • Geriatric Medicine (191)
  • Health Economics (405)
  • Health Informatics (1332)
  • Health Policy (662)
  • Health Systems and Quality Improvement (522)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10831)
  • Intensive Care and Critical Care Medicine (576)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (223)
  • Neurology (1842)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (357)
  • Occupational and Environmental Health (470)
  • Oncology (1006)
  • Ophthalmology (299)
  • Orthopedics (111)
  • Otolaryngology (184)
  • Pain Medicine (126)
  • Palliative Medicine (45)
  • Pathology (267)
  • Pediatrics (583)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1910)
  • Public and Global Health (4137)
  • Radiology and Imaging (678)
  • Rehabilitation Medicine and Physical Therapy (370)
  • Respiratory Medicine (551)
  • Rheumatology (226)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (178)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (110)
  • Urology (82)